Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730730 · ClinicalTrials.gov registry record · NA
The Complete® Self-Expanding Stent and Stent Delivery System Registry
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00730730 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 50 participants.
The verdict
NCT00730730, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to show if a new delivery system with a modified stent is safe in treating occluded iliac arteries in patients with peripheral vascular disease. The modified Complete SE delivery system is hypothesized to assist physicians with more accurate stent placement reducing the likelihood of stent 'jumping' seen with the use of many self-expanding stent systems.
Interventions
- DEVICE Complete SE Iliac Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00730730
The ClinicalTrials.gov registry entry for NCT00730730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Complete SE Iliac Stent is the first listed.
NCT00730730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00730730 about?
NCT00730730 is a clinical study titled "The Complete® Self-Expanding Stent and Stent Delivery System Registry". The purpose of this study is to show if a new delivery system with a modified stent is safe in treating occluded iliac arteries in patients with peripheral vascular disease. The modified Complete SE delivery system is hypothesized to assist physicians with more accurate stent placement reducing the ...
What is the current status of trial NCT00730730?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2007-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00730730?
The interventions under investigation include: Complete SE Iliac Stent (DEVICE).
Who is sponsoring clinical trial NCT00730730?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.